Method for preparing stem cells from human amniotic membrane
A technology for amniotic membrane epithelial cells and stem cells is applied in the field of separation of epithelial cells and mesenchymal stem cells in amniotic membrane, which can solve the problems of high contamination rate of amniotic membrane collection, affecting cell separation and culture, and poor cell activity.
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2014-03-19
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a cell separation technology, in particular to a method for separating epithelial cells and mesenchymal stem cells from amnion. Background technique
[0002] Amnion is the product of embryonic development. Amnion cells have stem cell characteristics and do not express human leukocyte antigens HLA-I and HLA- , There is no allogeneic immune rejection, so it is suitable for cell therapy. The stem cells in the amniotic membrane mainly include epithelial cells and mesenchymal stem cells.
[0003] Amnion epithelial cells have the characteristics of subtotipotent stem cells, have strong differentiation ability, can differentiate into three germ layers, and have no tumorigenicity and ethical problems. They are ideal seed cells for tissue engineering and cell therapy. Amniotic mesenchymal stem cells have a certain multi-directional differentiation potential, but compared with amniotic epithelial cells, their main feature is that they ...
Examples
Embodiment Construction
[0121] The present invention will be further described below in conjunction with accompanying drawing and embodiment:
[0122] A method for preparing stem cells from human amniotic membrane, which includes collecting, separating, culturing, freezing, and detecting; wherein, during the separation process, the amniotic membrane epithelial cells are digested with enzymes, and the amniotic membrane mesenchymal stem cells are then sliced by tissue method, the two are completed step by step.
[0123] The collection of the present invention specifically includes: putting the collected placenta into a sterile bag containing D-Hanks liquid placenta protection solution of 0.2 g / L streptomycin and 0.12 g / L penicillin, sealing the sterile bag and putting Put the collection box into the collection box, put the collection box into the constant temperature collection box, and send it to the stem cells within 24 hours with the constant temperature collection box.
[0124] The placenta coll...